MedPath

Imaging and Evolution of Pigmented Tumors of the Anterior Ocular System in Children

Recruiting
Conditions
Pigmented Tumours of the Anterior Ocular System in Children
Registration Number
NCT07120178
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

The investigators were interested in pigmented tumours of the anterior segment of the eye in children because there is very little data on their evolution. The nevus is the most common conjunctival tumour.

The challenge is to be able to adapt the child's follow-up according to the imaging and avoid an invasive procedure such as surgical excision if the imaging does not find any suspicious cells despite a change in size or colour. This would also make it possible to answer parents' questions about the potential evolution of the tumour. Finally, it would enable the frequency of monitoring to be personalised according to the data analysed. The tests are all non-invasive and painless.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
53
Inclusion Criteria
  • Patient who had a first dermato-ophthalmological consultation < 18 years old with pigmented tumors of the anterior ocular system
Exclusion Criteria
  • patient over 18 years old at first examination

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The size and pigmentation of the tumorDay 1

Measurement of the size of the tumor with dermatoscopy x20 in mm and pigmentation with the slit lamp as well as dermatoscopy x20 and x400

Secondary Outcome Measures
NameTimeMethod
Describe the evolution according to ageDay 1

Data collected from medical records

Describe the evolution according to sexDay 1

Data collected from medical records

Trial Locations

Locations (1)

CHU Saint-Etienne

🇫🇷

Saint-Étienne, France

CHU Saint-Etienne
🇫🇷Saint-Étienne, France
Jean Luc PERROT, Md, PhD
Contact
(0)477828508
j.luc.perrot@chu-st-etienne.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.